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INTRODUCTION

P
terygium is a common ocular surface disease. This is a wing-shaped fibrovascular lesion originated from the limbus and covered by epithelial cells. Pterygium can progress to the center of the cornea and causes loss of vision. Previous studies suggested that pterygium is an inflammatory, invasive, and highly vascularized growths, arise from activated limbus epithelial cells [1] [2] [3] [4] . Epidemiological studies demonstrated that chronic exposure to sunlight, especially ultraviolet (UV) irradiation, is the main cause of pterygium. Chronic UV radiation causes the development of pterygium and the recurrence of pterygium after its surgical excision [4] [5] [6] .
Experimental animal pterygium models have not been established previously [4] . Therefore, an in vitro model has been developed for the investigation of the pathogenesis and treatment of pterygium by using cultured human ocular surface cells from normal tissues or excised pterygium specimens [7] [8] [9] [10] . Pterygium tissue contains a high level of pro-inflammatory cytokines. UVB irradiation on human epithelial cells or fibroblasts isolated from normal ocular surface tissues or surgical excised pterygium specimens stimulate the expression and secretion of several pro-inflammatory cytokines and chemokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, and IL-8 [1, [7] [8] [9] [10] . This in vitro model has been repeatedly used for studying the pathogenesis of pterygium and for the search of medications that might be used for the prevention and treatment of pterygium [1, [7] [8] [9] [10] [11] . Chronic inflammatory reaction is involved in the pathogenesis of pterygium [1, 4, [7] [8] [9] . Up-regulation of various pro-inflammatory factors plays an important role in the pathogenesis of pterygium [7] [8] [9] . IL-6 is up-regulated in pterygium tissues.
This cytokine has a potent pro-inflammatory effect and also stimulates angiogenesis [7] [8] 12] . IL-8 (CXCL8) attracts neutrophil, T cell and monocytes into the tissues, leads to an inflammatory reaction [13] . IL-8 also induces angiogenesis [13] . All of these effects of these two cytokines lead to the development of inflammatory response and angiogenesis in the pterygium. The expression of IL-6 and IL-8 could be induced by UVB irradiation in normal corneal and pterygium tissues and their various cell components [7] [8] [9] 14] . Pterygium begins growing from limbus epithelial cells and UVB irradiation also induces inflammatory reactions in these cells earlier than other cell types lined ocular surface [2] [3] . Therefore, it is appropriate to use cultured limbus epithelial cells as an in vitro model for the investigation of the effects of UVB and various medication on the progress of pterygium Curcumin (diferuloylmethane), is a β-diketones, a yellow coloring agent extracted from turmeric, has a wide array of pharmacological and biological activities including chemopreventive, chemotherapeutic and anti-proliferative potentials [15] . In vitro study, experimental animal study and clinical trials indicated that curcumin can inhibit inflammation via the decrease of expression of various pro-inflammatory cytokines, chemokines, transcription factors and relevant signal pathways [15] [16] [17] [18] [19] . Curcumin inhibits UVB-induced expression of IL-6, IL-8 and TNF-α in keratinocytes through the downregulation of mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) signal pathways [15, [20] [21] . The effects of curcumin on UVB-induced inflammation in cells from pterygium or normal ocular surface tissues have not been previously reported. The purpose of the present study was to investigate the effects of curcumin on UVB-induced secretion of IL-6 and IL-8 from cultured human limbus epithelial cells and to explore the possibility of using curcumin in the prevention and treatment of pterygium. (2008) have been followed in the present study. The cornea with limbus and 2 mm wide of sclera were excised from the eyeball, then, the cornea and sclera were excised to leave approximately 1 mm on either side of the limbus. The limbus tissue was washed with Hank's solution (GIBCO, Grand Island, NY, USA) three times and than immersed in a 1.2 U/mL dispase II solution (Sigma) for 2h at 37 ℃ . After the enzymatic dissociation, the limbus epithelial cells were gently scraped by using a iris spatula under the stereo-microscope to isolate the limbus epithelial cells from the Bowman's membrane. Cells were collected and centrifuged. Pellets were resuspended by Ham's F12 nutrient mixture with 10% fetal bovine serum (all from GIBCO), seeded into the culture flask and incubated in a CO 2 -regulated incubator in humidified 95% air/5% CO 2 atmosphere. Seven days later, culture medium were replaced by the defined Keratinocyte-serum free medium (K-SFM, GIBCO). Cells were observed under phase-contrast microscope each day and the culture medium was changed three time a week. After reaching confluence, the limbus epithelial cells were detached using 0.25% trypsin solution (GIBCO), diluted 1:3 and subcultured. Cell cultures in the second passage were used in this study. Ultraviolet-B Irradiation Limbus epithelial cells were seeded into 12 well plates and grew to 75% confluence. Cultures were washed and covered with a thin layer of PBS before irradiation to remove potential phototoxic materials in culture medium. Cells were irradiated with various dosages of UVB using 20037 312 UVB bulbs (Staratagene, La Jolia, CA, USA), which emit UVB with a spectral peak at 312 nm. PMA 2100 Data Logging Radiometer (Solar Light, Inc., Genside, PA, USA) was used for monitoring and calibrating the intensity of UVB radiation. After UVB irradiation, cells were washed with PBS and cultured with fresh pre-warmed K-SFM for various periods. MTT Study Cell viability of limbus epithelial cells cultured with or without UVB irradiation was tested by the MTT assay. ) were seeded into 6-well plates. Curcumin was added to the culture to obtain a final concentrations at 20 μmol/L 24h later. Cultures were irradiated with UVB (20 mJ/cm 2 ) 1h later. Cells were harvested 24h later and protein was extracted. c-Jun N-terminal kinace (JNK) and p38 MAPK ELISA kits (with sensitivity at 0.8 U/mL) (Biosource, Camarillo, CA, USA) were used for the measurement of phosphorylated JNK and p38 MAPK levels in protein extracted from collected cells according to the manufacturer's instructions, respectively. The results (in triplicate) were expressed as percentages of the control, which were the cultures not treated by curcumin and UVB.
MATERIALS AND METHODS
Study of NF-κB Levels in Nuclear Extracts from Cultured
Limbus Epithelial Cells Limbus epithelial cells were seeded and treated as described above. Cells were scraped 30min after the treatment of UVB. Nuclear fraction was obtained by the treatment of collected cells with hypotonic buffer (BioSource). Nuclear extracts were obtained by the treatment of nuclear fraction with cell extraction buffer (BioSource). NF-κB ELISA kit (Invitrogen) was used for the measurement of NF-κB levels according to the manufacturer's instructions. The results (in triplicate) were expressed as percentages of the control, which were the cultures not treated by curcumin and UVB. 
Effects of Ultraviolet-B on NF-κB and Phosphorylated
Mitogen-activated Protein Kinase Levels UVB treatment induced significant increase of phosphorylated JNK and p38 MAPK levels in limbus epithelial cells (P<0.05) (Figure 4 ). UVB treatment also induced significant increase of NF-κB levels in nuclear extracts of the limbus epithelial cells (P<0.05) (Figure 4) .
Effects of Curcumin on UVB-induced Expression of NF-κB
and Phosphorylated Mitogen-activated Protein Kinase UVB-induced increase of phosphorylated JNK and p38 MAPK levels and NF-κB levels in limbus epithelial cells was significantly reduced by the treatment of curcumin (P<0.05) (Figure 4) .
Effects of Mitogen-activated Protein Kinase and NF-κB
Inhibitors on UVB-induced IL-6 and IL-8 Secretion JNK inhibitor, p38 MAPK inhibitor and NF-κB inhibitor significantly decreased the UVB-induced secretion of IL-6 secretion by cultured human limbus epithelial cells (P<0.05, as Figure   5A ). Secretion of IL-6 in cells treated with UVB and JNK or p38 MAPK inhibitor still slightly higher than that in cells not treated with UVB (P<0.05); while secretion of IL-6 in cells treated with UVB and NF-κB inhibitor did not differ from cells not treated with UVB (P>0.05) ( Figure 5A ). These results suggested that NF-κB inhibitor can completely block the UVBinduced secretion of IL-6 in limbus epithelial cells, while JNK or p38 MAPK inhibitor only had a partially blocking effect.
DISCUSSION
The effects of UVB on the production of IL-6 and IL-8 of limbus epithelial cells have not been reported previously.
In the present study, UVB induced significantly increase of secretion of IL-6 and IL-8 by cultured limbus epithelial cells. This is consistent with previously reports, which described the UVB-induced IL-6 and IL-8 by other types of ocular surface epithelial cells, such as normal corneal epithelial cells or pterygium epithelial cells [7] [8] [9] . The signal pathways involved in UVB-induced production of IL-6 and IL-8 by corneal epithelial cells, pterygium epithelial cells and keratinocytes include MAPK and NF-κB pathways [7] [8] [9] [20] [21] . UVB may directly activate the NF-κB in the cytoplasm. Activated NF-κB translocates to the nuclei and work as a transcription factor for stimulating the expression of various pro-inflammatory cytokines, including IL-6 and IL-8 [21] . Alternatively, UVB may first activate MAPK signal pathway. The activated MAPKs can translocate into the nucleus and phosphorylates the target transcription factors, such as NF-κB. Our study suggested that curcumin inhibited the UVB-induced expression of IL-6 and IL-8 via MAPK and NF-κB signal pathways. This result is consistent with the previous reports that UVB-induced production of IL-6 and IL-8 is relevant to the activation of MAPK and NF-κB signal pathways in epithelial cells from normal cornea or pterygium specimens and in keratinocytes [7] [8] [9] [20] [21] . The present study revealed that curcumin at low and nonlethal dosages (5-20 μmol/L) does not affect the constitutive secretion of IL-6 and IL-8 by limbus epithelial cells, but curcumin at the same dosages can significantly inhibits UVBinduced secretion of IL-6 and IL-8 in limbus epithelial cells. This results are consistent with the results found in previous studies that curcumin can inhibit UVB-induced production and secretion of IL-6 and IL-8 in keratinocytes [20] [21] .
Curcumin is a natural anti-inflammatory compound with a long history of use, has been used as a remedy for the treatment and prevention of inflammatory diseases [16] [17] [18] [19] . Aggarwal et al [16] reported that more than 60 clinical trials had been conducted for studying the efficacy and safety of curcumin. In addition to these studies, another 35 clinical trials have evaluated the efficacy of curcumin. Curcumin was found to be effective in the treatment of various chronic inflammatory diseases including psoriasis, inflammatory bowel diseases and different types of arthritis, such as rheumatoid arthritis and osteoarthritis [16, 18] . It has even been demonstrated to be effective in the treatment of other severe diseases such as Alzheimer's [22] , cystic fibrosis [23] , and AIDS [24] . Clinical trials also demonstrated that curcumin is a safe, nontoxic remedy, can be given orally and is quite safe and affordable [15] [16] [17] [18] [19] . The main limitation of curcumin is its insolubility in aqueous systems. Various attempts to enhance the bioavailability and efficacy of curcumin have been reported by the encapsulation of curcumin into liposomes, phospholipid complexes or nanoparticle. The primary aim of these studies is to achieve increased solubilization of curcumin and, at the same time, to protect curcumin against inactivation by hydrolysis [13, 25] .
Therefore, in the future, curcumin can be used not only as an oral nutrition supplement, but also can be used locally, such as the eye drops for the treatment of various ocular inflammatory diseases. The present study found that curcumin at low and safe dosages significantly inhibits the UVB-induced secretion of IL-6 and IL-8 by cultured limbus epithelial cells; but does not affect the constitutive secretion of IL-6 and IL-8. These results suggest that curcumin may be a promising agent to be explored for the prevention of progress of pterygium, and also may be used for the prevention of recurrence of pterygium after its surgical excision.
